iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Jul 02
 +0.45 / +0.12%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.


1 month+1.93% 3 years+40.86%
3 months+9.03% 5 years+37.39%
1 year+39.92% Since inception+9.67%
Data through 07/03/2015

Quote Details

Previous close$369.90
Open day’s range368.06 – 372.10
Net asset value (NAV)370.21 (07/02/2015)
Daily volume840,802
Average volume (3 months)1,734,331
Data as of 4:14pm ET, 07/02/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+37.39%+22.89%
Expense Gross exp ratio0.48%0.47%
Risk 5 year sharpe ratio1.831.68
Net assets$8.8B$1.9B
Average market cap$18.7B$38.6B
Average P/E27.524.7
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences8.32%
AMGN Amgen7.60%
BIIB Biogen7.44%
REGN Regeneron Pharmaceuticals7.24%
CELG Celgene7.23%
MYL Mylan NV5.16%
VRTX Vertex Pharmaceuticals Inc4.12%
ILMN Illumina Inc4.05%
ALXN Alexion Pharmaceuticals Inc3.49%
BMRN Biomarin Pharmaceutical Inc2.90%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers